CHIT1, another putative marker of microglial activation, showed more pronounced elevations in the CSF of Aβ+ MCI and AD patients, supporting prior observations of up-regulated CHIT1 in progressive brain illnesses [53, 58], and warranting further investigation of the role of chitinases in immune response and neurodegeneration. Here, CHIT1 is linked to Alzheimer disease.